- Orion Corporation
-
Orion Oyj Type Julkinen osakeyhtiö Traded as OMX: ORNBV Industry Pharmaceutical industry Founded 1917 Headquarters Espoo, Finland Key people Timo Lappalainen (President and CEO), Hannu Syrjänen (Chairman) Products Pharmaceuticals, active pharmaceutical ingredients and diagnostic tests Revenue €849.9 million (2010)[1] Operating income €254.2 million (2010)[1] Profit €184.7 million (2010)[1] Total assets €745.8 million (end 2010)[1] Total equity €467.4 million (end 2010)[1] Employees 3,140 (average, 2010)[1] Website www.orion.fi Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a Finnish company, which develops, manufactures and markets pharmaceuticals, active pharmaceutical ingredients and diagnostic tests for global markets. The company also has a large R&D unit in Turku.
Orion has annual net sales of approximately EUR 500 million; its class A and B shares are listed on the Helsinki Stock Exchange.
Products
-
- Indalgin (indometacin, ethylmorphine)
-
- Glimepirid Orion (glimepiride)
- Metforem (metformin)
- Origlucon (glibenclamide)
- Gastric acid related drugs
-
- Ranimex (ranitidine)
- Zolt (lansoprazole)
-
- Daktarin (miconazole)
- Elmex (olaflur)
- Motion sickness drugs
-
- Cohemin (cyanocobalamin)
- Neuramin (thiamine)
-
- Marevan (warfarin)
- Cardiovascular drugs
-
- Digoxin (digoxin)
- Disomet (disopyramide)
- Dopmin (dopamine)
- Kiniduron (quinidine)
- Lidocard (lidocaine)
- Nitro (glyceryl trinitrate)
- Nitrosid (isosorbide dinitrate)
- Ormox (isosorbide mononitrate)
- Simdax (levosimendan)
- Antihypertensive drugs
-
- Amlodipin Orion (amlodipine)
- Carvedilol Orion Pharma (carvedilol)
- Dilzem (diltiazem)
- Escor (nilvadipine)
- Espesil (acebutolol)
- Lisipril (lisinopril)
- Lopril (captopril)
- Nifangin (nifedipine)
- Orloc (bisoprolol)
- Pinloc (pindolol)
- Pratsiol (prazosin)
- Propral (propranolol)
- Selopral (metoprolol)
- Verpamil (verapamil)
- Lisipril Comp (lisinopril and hydrochlorothiazide)
- Orloc Comp (bisoprolol and hydrochlorothiazide)
-
- Diurex (hydrochlorothiazide and amiloride)
- Furesis (furosemide)
- Furesis Comp (furosemide and triamterene)
- Hydrex (hydrochlorothiazide)
- Indapamide Orion (indapamide)
- Spiresis (spironolactone)
- Uretren Comp (trichlormethiazide and triamterene)
-
- Atorvastatin Orion (atorvastatin)
- Lovacol (lovastatin)
- Pravastatin Orion (pravastatin)
- Simvastatin Orion (simvastatin)
References
- ^ a b c d e f "Annual Results 2010". Orion. http://www.orion.fi/Documents/Osavuosikatsaukset/EN_Orion_FY2010.pdf. Retrieved 9 February 2011.
External links
OMX Helsinki 25 companies of Finland Cargotec · Elisa · Fortum · Kemira · Kesko · KONE · Konecranes · Metso · Neste Oil · Nokia · Nokian Tyres · Nordea · Orion Corporation · Outokumpu · Outotec · Pohjola Bank · Rautaruukki · Sampo · Sanoma · Stora Enso · Talvivaara Mining Company · TeliaSonera · UPM · Wärtsilä · YIT
Categories:- Companies listed on the OMX exchanges
- Companies based in Espoo
- Companies established in 1917
- Companies listed on the Helsinki Stock Exchange
- Pharmaceutical companies of Finland
Wikimedia Foundation. 2010.